1. Home
  2. PPBT vs PBM Comparison

PPBT vs PBM Comparison

Compare PPBT & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • PBM
  • Stock Information
  • Founded
  • PPBT 2010
  • PBM 1994
  • Country
  • PPBT Israel
  • PBM Canada
  • Employees
  • PPBT N/A
  • PBM N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • PBM
  • Sector
  • PPBT Health Care
  • PBM
  • Exchange
  • PPBT Nasdaq
  • PBM NYSE
  • Market Cap
  • PPBT 8.7M
  • PBM 5.3M
  • IPO Year
  • PPBT N/A
  • PBM N/A
  • Fundamental
  • Price
  • PPBT $3.10
  • PBM $1.40
  • Analyst Decision
  • PPBT Strong Buy
  • PBM
  • Analyst Count
  • PPBT 2
  • PBM 0
  • Target Price
  • PPBT $126.50
  • PBM N/A
  • AVG Volume (30 Days)
  • PPBT 28.8K
  • PBM 417.9K
  • Earning Date
  • PPBT 03-04-2025
  • PBM 02-02-2025
  • Dividend Yield
  • PPBT N/A
  • PBM N/A
  • EPS Growth
  • PPBT N/A
  • PBM N/A
  • EPS
  • PPBT N/A
  • PBM N/A
  • Revenue
  • PPBT N/A
  • PBM N/A
  • Revenue This Year
  • PPBT N/A
  • PBM N/A
  • Revenue Next Year
  • PPBT N/A
  • PBM N/A
  • P/E Ratio
  • PPBT N/A
  • PBM N/A
  • Revenue Growth
  • PPBT N/A
  • PBM N/A
  • 52 Week Low
  • PPBT $2.00
  • PBM $1.15
  • 52 Week High
  • PPBT $20.60
  • PBM $323.25
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 41.53
  • PBM 41.45
  • Support Level
  • PPBT $2.90
  • PBM $1.15
  • Resistance Level
  • PPBT $3.20
  • PBM $1.59
  • Average True Range (ATR)
  • PPBT 0.21
  • PBM 0.20
  • MACD
  • PPBT 0.00
  • PBM 0.03
  • Stochastic Oscillator
  • PPBT 42.19
  • PBM 27.53

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: